Moors & Cabot, Inc. Abbott Laboratories Call Options Transaction History

Moors & Cabot, Inc.

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $22,461 - $27,390	197 Added 6566.67%	200 $2,000
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $92,077 - $112,743	-797 Reduced 99.63%	3 $2,000
Q3 2021 Dec 08, 2021	BUY	$116.66 - $129.06 $93,328 - $103,248	800 New	800 $9,000
Q3 2021 Nov 05, 2021	SELL	$116.66 - $129.06 $93,328 - $103,248	-800 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$105.79 - $124.53 $338,528 - $398,496	-3,200 Reduced 80.0%	800 $8,000
Q4 2019 Jan 28, 2020	BUY	$78.51 - $87.4 $314,040 - $349,600	4,000 New	4,000 $2,000

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

Stay updated on Moors & Cabot, Inc. with notifications on news.